The Vice President of the Emilia-Romagna Region visited Aferetica's headquarters to see firsthand the company's progress in innovation, advanced manufacturing and Made in Italy excellence in the life sciences sector.
The scientific contributions from the 4ᵗʰ Workshop Purification Therapies (Milan, September 19–20, 2025) are now collected in a special supplement of Transplant International Journal.
Quotidiano Nazionale features Aferetica following its selection for the Premio Paolo Mascagni 2026, recognising entrepreneurial excellence in the territory.
Under the PMI2023 call, the SUPER program has been launched to develop the next generation of the PerLifeᴾᴿᴼ® system, introducing advanced technologies, increased automation, and improved clinical performance.
PerTravel® platform intended use has been officially extended to include lungs preservation and transportation.
The VIRTUALAB project has been successfully completed, delivering a digital technical lab that enhances remote support and online training, improving efficiency, response times, and accessibility across Europe.
FARE Magazine highlights Aferetica’s journey: from its early days in a post-earthquake container in Mirandola to becoming an international reference in extracorporeal purification therapies and organ transplantation support.
PerLife®ᵖʳᵒ expands across Europe through an integrated pathway of innovation and competitiveness in organ perfusion.
Aferetica’s Co-Founder Stefano Rimondi took part in “Eccellenze in Sanità – Innovation, People and Territories in Emilia-Romagna”
Following last year’s success, Aferetica confirms its place among the top-performing companies in Bologna province!
